Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:AEMD NASDAQ:ITOC NASDAQ:LUCY NASDAQ:VVOS On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAEMDAethlon Medical$0.58-2.6%$1.46$0.58▼$27.40$1.39M1.41148,981 shs61,237 shsITOCItonic$0.27-5.4%$0.32$0.24▼$32.00$4.52M2.75117,532 shs59,968 shsLUCYInnovative Eyewear$0.65-6.4%$0.90$0.65▼$2.27$4.17M2.7113.56 million shs194,451 shsVVOSVivos Therapeutics$0.39+0.6%$0.54$0.36▼$5.69$5.46M6.16824,076 shs152,620 shs7 Stocks to Buy And Hold ForeverClick the link to see MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAEMDAethlon Medical0.00%-10.05%-34.38%-73.42%-95.82%ITOCItonic0.00%-6.13%-14.52%-29.14%+26,499,900.00%LUCYInnovative Eyewear0.00%-19.05%-14.37%-38.02%-70.95%VVOSVivos Therapeutics0.00%-6.29%-9.42%-53.34%-92.99%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAEMDAethlon Medical$0.58-2.6%$1.46$0.58▼$27.40$1.39M1.41148,981 shs61,237 shsITOCItonic$0.27-5.4%$0.32$0.24▼$32.00$4.52M2.75117,532 shs59,968 shsLUCYInnovative Eyewear$0.65-6.4%$0.90$0.65▼$2.27$4.17M2.7113.56 million shs194,451 shsVVOSVivos Therapeutics$0.39+0.6%$0.54$0.36▼$5.69$5.46M6.16824,076 shs152,620 shs7 Stocks to Buy And Hold ForeverClick the link to see MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAEMDAethlon Medical0.00%-10.05%-34.38%-73.42%-95.82%ITOCItonic0.00%-6.13%-14.52%-29.14%+26,499,900.00%LUCYInnovative Eyewear0.00%-19.05%-14.37%-38.02%-70.95%VVOSVivos Therapeutics0.00%-6.29%-9.42%-53.34%-92.99%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAEMDAethlon Medical 1.50ReduceN/AN/AITOCItonic 1.00SellN/AN/ALUCYInnovative Eyewear 1.50ReduceN/AN/AVVOSVivos Therapeutics 2.25Hold$2.80612.29% UpsideCurrent Analyst Ratings BreakdownLatest AEMD, VVOS, LUCY, and ITOC Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails7/17/2026AEMDAethlon Medical Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (E+)7/17/2026LUCYInnovative Eyewear Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (E+)7/17/2026VVOSVivos Therapeutics Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (E+)6/5/2026ITOCItonic Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeSell (E+) ➝ Sell (D-)6/4/2026VVOSVivos Therapeutics Ascendiant Capital MarketsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$3.00 ➝ $3.106/3/2026LUCYInnovative Eyewear Maxim GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeBuy ➝ Hold5/8/2026ITOCItonic Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (E+)(Data available from 7/26/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAEMDAethlon MedicalN/AN/AN/AN/A$3.11 per shareN/AITOCItonic$520K8.69N/AN/A$0.48 per share0.55LUCYInnovative Eyewear$2.66M1.57N/AN/A$1.69 per share0.39VVOSVivos Therapeutics$17.44M0.31N/AN/A($0.16) per share-2.46Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAEMDAethlon Medical-$7.15M-$14.69N/AN/AN/AN/A-137.73%-105.87%8/12/2026 (Estimated)ITOCItonic-$5.10MN/AN/AN/AN/AN/AN/AN/AN/ALUCYInnovative Eyewear-$7.59M-$1.69N/AN/AN/A-272.42%-83.37%-76.02%8/13/2026 (Estimated)VVOSVivos Therapeutics-$21.17M-$2.14N/AN/AN/A-127.70%-2,325.64%-98.12%8/18/2026 (Estimated)Latest AEMD, VVOS, LUCY, and ITOC EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/18/2026Q2 2026VVOSVivos Therapeutics-$0.42N/AN/AN/A$5.63 millionN/A8/13/2026Q2 2026LUCYInnovative Eyewear-$0.37N/AN/AN/A$0.90 millionN/A8/12/2026Q1 2027AEMDAethlon Medical-$0.7850N/AN/AN/AN/AN/A5/20/2026Q1 2026VVOSVivos Therapeutics-$0.45-$0.52-$0.07-$0.52$4.35 million$5.14 million5/14/2026Q1 2026LUCYInnovative Eyewear-$0.47-$0.37+$0.10-$0.37$0.70 million$0.77 millionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthAEMDAethlon MedicalN/AN/AN/AN/AN/AITOCItonicN/AN/AN/AN/AN/ALUCYInnovative EyewearN/AN/AN/AN/AN/AVVOSVivos TherapeuticsN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAEMDAethlon MedicalN/A3.853.85ITOCItonicN/A8.838.72LUCYInnovative EyewearN/A8.026.09VVOSVivos TherapeuticsN/A0.270.27Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAEMDAethlon Medical1.99%ITOCItonicN/ALUCYInnovative Eyewear0.96%VVOSVivos Therapeutics26.35%Insider OwnershipCompanyInsider OwnershipAEMDAethlon Medical0.71%ITOCItonicN/ALUCYInnovative Eyewear1.66%VVOSVivos Therapeutics2.10%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAEMDAethlon Medical102.37 million2.35 millionNo DataITOCItonicN/A17.05 millionN/AN/ALUCYInnovative Eyewear96.40 million6.30 millionNot OptionableVVOSVivos Therapeutics16013.90 million13.60 millionOptionableAEMD, VVOS, LUCY, and ITOC HeadlinesRecent News About These CompaniesVivos Therapeutics (VVOS) Stock Fair Value Falls After Analyst Target CutsJuly 18, 2026 | finance.yahoo.comVivos Therapeutics (VVOS) Stock Sees Fair Value Moves Lower As Analysts Reset Growth AssumptionsJuly 3, 2026 | finance.yahoo.comVivos’ Vida® Appliance Shows Statistically Significant Improvement in Insomnia Severity in 100% of Study ParticipantsJune 30, 2026 | markets.businessinsider.comVivos' Vida® Appliance Shows Statistically Significant Improvement in Insomnia Severity in 100% of Study ParticipantsJune 30, 2026 | globenewswire.comVivos Therapeutics and Streeterville Extend Timeframe of Strategic Financing Agreement and Reaffirm Commitment to Convert Debt Into Common Stock and Perpetual Preferred EquityJune 22, 2026 | globenewswire.comVivos Therapeutics Announces Intent to File a Registration Statement for a Proposed Rights OfferingJune 11, 2026 | globenewswire.comVivos Therapeutics Announces Key Collaboration Agreement with Multi-Location Florida Cardiology Group to Extend Much Needed Sleep Apnea and Insomnia Diagnosis and Treatment to ...June 10, 2026 | markets.businessinsider.comVivos Therapeutics Announces Key Collaboration Agreement with Multi-Location Florida Cardiology Group to Extend Much Needed Sleep Apnea and Insomnia Diagnosis and Treatment to Cardiovascular PatientsJune 10, 2026 | globenewswire.comVivos Therapeutics, Inc. to Present at The Small Cap Showcase & WTR Insights on June 9, 2026June 8, 2026 | quiverquant.comQVivos Therapeutics To Participate in the Small Cap Showcase & WTR Insights on June 9, 2026June 8, 2026 | globenewswire.comVivos Therapeutics Announces Debt Exchange Agreement with Streeterville Capital to Strengthen Financial PositionJune 5, 2026 | quiverquant.comQVivos Therapeutics Announces Binding Agreement for Senior Debt-to-Equity Exchange of Up to $4.5 Million from Streeterville Capital to Support Continued Nasdaq ListingJune 5, 2026 | globenewswire.comVivos Therapeutics Inc (VVOS) Q1 2026 Earnings Call Highlights: Revenue Surges Amid Strategic ShiftsMay 29, 2026 | finance.yahoo.comVivos Therapeutics Balances Rapid Growth With Cash StrainMay 22, 2026 | tipranks.comVivos Therapeutics Earnings Call: Growth Meets Cash StrainMay 21, 2026 | tipranks.comVivos Therapeutics, Inc: Vivos Therapeutics Reports First Quarter 2026 Financial Results and Provides Operational UpdateMay 21, 2026 | finanznachrichten.deVivos Therapeutics, Inc. (VVOS) Q1 2026 Earnings Call TranscriptMay 21, 2026 | seekingalpha.comVivos Therapeutics Reports First Quarter 2026 Financial Results and Provides Operational UpdateMay 20, 2026 | globenewswire.comVivos Therapeutics Delays Quarterly FilingMay 15, 2026 | tipranks.comAnalysts see 200%+ upside in these 3 high-risk stocks: here's why?May 9, 2026 | invezz.comINew MarketBeat Followers Over TimeMedia Sentiment Over TimeAEMD, VVOS, LUCY, and ITOC Company DescriptionsAethlon Medical NASDAQ:AEMD$0.58 -0.02 (-2.63%) Closing price 07/24/2026 04:00 PM EasternExtended Trading$0.61 +0.03 (+4.33%) As of 07/24/2026 06:40 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Aethlon Medical, Inc., a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses and use in organ transplantation. The company was incorporated in 1999 and is based in San Diego, California.Itonic NASDAQ:ITOC$0.26 -0.02 (-5.36%) Closing price 07/24/2026 03:59 PM EasternExtended Trading$0.28 +0.01 (+4.15%) As of 07/24/2026 05:22 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.iTonic Holdings Ltd., a healthcare solutions provider, develops and commercializes treatment software and devices used for brachytherapy. Its proprietary treatment planning system is a radioactive particle implantation, a radiotherapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. The company offers FTTPS, a treatment planning system for treating various malignant tumors, which could determine the target volume, prescription dose, and dose limitation to protect organs at risks and produce dose distribution plan for brachytherapy for cancer patients. The company was formerly known as Pheton Holdings Ltd and changed its name to iTonic Holdings Ltd. in January 2026. iTonic Holdings Ltd. was founded in 1998 and is headquartered in Beijing, China. iTonic Holdings Ltd. operates as a subsidiary of ZJW (BVI) LTD.Innovative Eyewear NASDAQ:LUCY$0.65 -0.04 (-6.40%) Closing price 07/24/2026 04:00 PM EasternExtended Trading$0.67 +0.02 (+2.49%) As of 07/24/2026 07:28 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Innovative Eyewear, Inc. develops and sells smart eyeglasses and sunglasses. The company's flagship product is Lucyd Lyte glasses that enable the wearer to listen to music, take and make calls, and use voice assistants to perform various smartphone tasks hands-free. It also offers Vyrb, a social media application that enables the user to receive and send posts through Lucyd Lyte smart glasses with voice. In addition, the company launches an application, Lucyd app for iOS/Android users. It sells its products through various e-commerce, and retail store and distribution channels. Innovative Eyewear, Inc. has a license agreement with Lucyd Ltd. The company was incorporated in 2019 and is headquartered in North Miami, Florida. Innovative Eyewear, Inc. is a subsidiary of Lucyd Ltd.Vivos Therapeutics NASDAQ:VVOS$0.39 +0.00 (+0.64%) Closing price 07/24/2026 04:00 PM EasternExtended Trading$0.42 +0.02 (+6.08%) As of 07/24/2026 06:31 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Vivos Therapeutics, Inc., a medical technology company, develops and commercializes treatment modalities for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers The Vivos Method, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring. The company also offers VivoScore Program, a screening and home sleep test in adults and children. It markets and sells its appliances, and related treatments and services to licensed professionals, primarily general dentists in the United States and Canada. Vivos Therapeutics, Inc. was founded in 2016 and is based in Littleton, Colorado. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 07/20- 07/24 Telecom Earnings Reveal a Sector That Finally Looks Healthier AMD and Cerbras Create A New Blueprint For Hardware Intel Earnings Reveal Whether the Chip Selloff Created a Buy CrowdStrike’s Cerebras Deal Puts Its AI Security Strategy to the Test Defense Earnings Show Readiness Now and Modernization Ahead Freeport McMoRan Post-Earnings: Why Good Enough May Finally Be Good Enough Tesla Just Delivered Record Sales—So Why Did the Stock Sell Off? Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
